| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DELCATH SYSTEMS, INC. | GM INTERVENTIONAL ONCOLOGY | Stock Option (Right to Buy) | 56,500 | 17 Feb 2026 | Direct | ||
| DELCATH SYSTEMS, INC. | GM INTERVENTIONAL ONCOLOGY | Restricted Stock Units | 28,250 | 17 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYSTEMS, INC. | 17 Feb 2026 | 2 | $0 | 4 | GM INTERVENTIONAL ONCOLOGY | 18 Feb 2026, 21:30 |
| DCTH | DELCATH SYSTEMS, INC. | 07 Feb 2025 | 1 | $0 | 4 | GM INTERVENTIONAL ONCOLOGY | 07 Feb 2025, 19:14 |
| DCTH | DELCATH SYSTEMS, INC. | 19 Mar 2024 | 1 | +$50,001 | 4 | GM INTERVENTIONAL ONCOLOGY | 19 Mar 2024, 16:58 |
| DCTH | DELCATH SYSTEMS, INC. | 12 Feb 2024 | 1 | $0 | 4 | VP COMMERCIAL OPERATIONS | 14 Feb 2024, 16:44 |
| DCTH | DELCATH SYSTEMS, INC. | 12 Jun 2023 | 1 | $0 | 4 | Vice President Commercial Operations | 22 Jun 2023, 16:14 |
| DCTH | DELCATH SYSTEMS, INC. | 08 Feb 2023 | 1 | $0 | 4 | VP COMMERCIAL OPERATIONS | 26 Jan 2024, 16:25 |
| DCTH | DELCATH SYSTEMS, INC. | 04 May 2022 | 0 | $0 | 3 | Vice President Commercial Operations Exhibit List: Exhibit 24 - Power of Attorney | 16 May 2022, 19:38 |